BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tonelli R, Cocconcelli E, Lanini B, Romagnoli I, Florini F, Castaniere I, Andrisani D, Cerri S, Luppi F, Fantini R, Marchioni A, Beghè B, Gigliotti F, Clini EM. Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: a multicenter prospective study. BMC Pulm Med 2017;17:130. [PMID: 29017478 DOI: 10.1186/s12890-017-0476-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Polastri M, Clini E, Nava S, Vitacca M, Ambrosino N. Evaluation of health-related quality of life in pulmonary diseases. International Journal of Therapy and Rehabilitation 2018;25:380-1. [DOI: 10.12968/ijtr.2018.25.8.380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Pettersson H, Alexanderson H, Poole JL, Varga J, Regardt M, Russell AM, Salam Y, Jensen K, Mansour J, Frech T, Feghali-Bostwick C, Varjú C, Baldwin N, Heenan M, Fligelstone K, Holmner M, Lammi MR, Scholand MB, Shapiro L, Volkmann ER, Saketkoo LA. Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS). Best Pract Res Clin Rheumatol 2021;:101695. [PMID: 34217607 DOI: 10.1016/j.berh.2021.101695] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Milne KM, Ibrahim-Masthan M, Scheeren RE, James MD, Phillips DB, Moran-Mendoza O, Ja N, O'Donnell DE. Inspiratory neural drive and dyspnea in interstitial lung disease: Effect of inhaled fentanyl. Respir Physiol Neurobiol 2020;282:103511. [PMID: 32758677 DOI: 10.1016/j.resp.2020.103511] [Reference Citation Analysis]
4 Povitz M, Li L, Hosein K, Shariff S, Mura M. Implementing an interstitial lung disease clinic improves survival without increasing health care resource utilization. Pulm Pharmacol Ther 2019;56:94-9. [PMID: 30930173 DOI: 10.1016/j.pupt.2019.03.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Guler SA, Hur SA, Lear SA, Camp PG, Ryerson CJ. Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort study. Respir Res 2019;20:56. [PMID: 30866948 DOI: 10.1186/s12931-019-1019-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
6 Molgat-Seon Y, Schaeffer MR, Ryerson CJ, Guenette JA. Cardiopulmonary Exercise Testing in Patients With Interstitial Lung Disease. Front Physiol 2020;11:832. [PMID: 32754054 DOI: 10.3389/fphys.2020.00832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Faverio P, De Giacomi F, Bonaiti G, Stainer A, Sardella L, Pellegrino G, Sferrazza Papa GF, Bini F, Bodini BD, Carone M, Annoni S, Messinesi G, Pesci A. Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights. Int J Med Sci 2019;16:967-80. [PMID: 31341410 DOI: 10.7150/ijms.32752] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Senanayake S, Harrison N, Lewis M. Influence of physical rehabilitation on heart rate dynamics in patients with idiopathic pulmonary fibrosis. J Exerc Rehabil 2019;15:160-9. [PMID: 30899753 DOI: 10.12965/jer.1836452.226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Candemir I, Ergun P, Demir N. Pleuroparenchymal fibroelastosis: from diagnosis to pulmonary rehabilitation. BMJ Case Rep 2021;14:e236754. [PMID: 34130969 DOI: 10.1136/bcr-2020-236754] [Reference Citation Analysis]
10 Saketkoo LA, Obi ON, Patterson KC, Russell AM. Ageing with Interstitial lung disease: preserving health and well being. Curr Opin Pulm Med 2022;28:321-36. [PMID: 35749798 DOI: 10.1097/MCP.0000000000000880] [Reference Citation Analysis]
11 Marco JL, Collins BF. Clinical manifestations and treatment of antisynthetase syndrome. Best Pract Res Clin Rheumatol 2020;34:101503. [PMID: 32284267 DOI: 10.1016/j.berh.2020.101503] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
12 Mahendran K, Naidu B. The key questions in rehabilitation in thoracic surgery. J Thorac Dis 2018;10:S924-30. [PMID: 29744219 DOI: 10.21037/jtd.2018.03.147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Torrisi SE, Kahn N, Vancheri C, Kreuter M. Evolution and treatment of idiopathic pulmonary fibrosis. Presse Med 2020;49:104025. [PMID: 32437841 DOI: 10.1016/j.lpm.2020.104025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Somogyi V, Chaudhuri N, Torrisi SE, Kahn N, Müller V, Kreuter M. The therapy of idiopathic pulmonary fibrosis: what is next? Eur Respir Rev 2019;28:190021. [PMID: 31484664 DOI: 10.1183/16000617.0021-2019] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 16.7] [Reference Citation Analysis]
15 Aryal S, Nathan SD. An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis. Expert Opinion on Emerging Drugs 2018;23:159-72. [DOI: 10.1080/14728214.2018.1471465] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
16 Dawod YT, Cook NE, Graham WB, Madhani-Lovely F, Thao C. Smoking-associated interstitial lung disease: update and review. Expert Rev Respir Med 2020;14:825-34. [PMID: 32379511 DOI: 10.1080/17476348.2020.1766971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Gille T, Laveneziana P. Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency. Eur Respir Rev 2021;30:200355. [PMID: 34853093 DOI: 10.1183/16000617.0355-2020] [Reference Citation Analysis]
18 Barman A, Sinha MK, Sahoo J, Jena D, Patel V. Respiratory Rehabilitation in Patients Recovering from Severe Acute Respiratory Syndrome: A Systematic Review and Meta-analysis. Heart & Lung 2022. [DOI: 10.1016/j.hrtlng.2022.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Mori Y, Yamano Y, Kataoka K, Yokoyama T, Matsuda T, Kimura T, Ogawa T, Watanabe F, Kondoh Y. Pulmonary rehabilitation for idiopathic pleuroparenchymal fibroelastosis: A retrospective study on its efficacy, feasibility, and safety. Respir Investig 2021;59:849-58. [PMID: 34561207 DOI: 10.1016/j.resinv.2021.08.003] [Reference Citation Analysis]
20 Collins BF, Luppi F. Diagnosis and Management of Fibrotic Interstitial Lung Diseases. Clin Chest Med 2021;42:321-35. [PMID: 34024407 DOI: 10.1016/j.ccm.2021.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Kahn N, Welte T, Neurohr C, Schwaiblmair M, Held M, Bahmer T, Oqueka T, Frankenberger M, Behr J. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry. Respir Res 2019;20:59. [PMID: 30876420 DOI: 10.1186/s12931-019-1020-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 11.7] [Reference Citation Analysis]
22 Yohannes AM. Depression and anxiety in patients with interstitial lung disease. Expert Rev Respir Med 2020;14:859-62. [PMID: 32460643 DOI: 10.1080/17476348.2020.1776118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Nardi P, Pellegrino A, Pisano C, Vacirca SR, Anselmi D, Saulle S, Dandi R, Romano A, Servadio A, Gianlorenzi A, Ruvolo G. The effect of preoperative respiratory physiotherapy and motor exercise in patients undergoing elective cardiac surgery: short-term results. Kardiochir Torakochirurgia Pol 2019;16:81-7. [PMID: 31410095 DOI: 10.5114/kitp.2019.86360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
24 Makhdami N, Farooqi M, Thom-fernandes C, Raghavan NG. Pulmonary rehabilitation in interstitial lung diseases. Current Opinion in Pulmonary Medicine 2020;26:470-6. [DOI: 10.1097/mcp.0000000000000700] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Sciriha A, Lungaro-Mifsud S, Fsadni P, Scerri J, Montefort S. Pulmonary Rehabilitation in patients with Interstitial Lung Disease: The effects of a 12-week programme. Respir Med 2019;146:49-56. [PMID: 30665518 DOI: 10.1016/j.rmed.2018.11.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
26 Cottin V, Bonniaud P, Cadranel J, Crestani B, Jouneau S, Marchand-Adam S, Nunes H, Wémeau-Stervinou L, Bergot E, Blanchard E, Borie R, Bourdin A, Chenivesse C, Clément A, Gomez E, Gondouin A, Hirschi S, Lebargy F, Marquette CH, Montani D, Prévot G, Quetant S, Reynaud-Gaubert M, Salaun M, Sanchez O, Trumbic B, Berkani K, Brillet PY, Campana M, Chalabreysse L, Chatté G, Debieuvre D, Ferretti G, Fourrier JM, Just N, Kambouchner M, Legrand B, Le Guillou F, Lhuillier JP, Mehdaoui A, Naccache JM, Paganon C, Rémy-Jardin M, Si-Mohamed S, Terrioux P; OrphaLung. [French practical guidelines for the diagnosis and management of IPF - 2021 update, full version]. Rev Mal Respir 2022:S0761-8425(22)00035-3. [PMID: 35752506 DOI: 10.1016/j.rmr.2022.01.014] [Reference Citation Analysis]
27 Zanatta E, Codullo V, Avouac J, Allanore Y. Systemic sclerosis: Recent insight in clinical management. Joint Bone Spine 2020;87:293-9. [PMID: 31568838 DOI: 10.1016/j.jbspin.2019.09.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
28 Saketkoo LA, Russell AM, Jensen K, Mandizha J, Tavee J, Newton J, Rivera F, Howie M, Reese R, Goodman M, Hart P, Strookappe B, De Vries J, Rosenbach M, Scholand MB, Lammi MR, Elfferich M, Lower E, Baughman RP, Sweiss N, Judson MA, Drent M. Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes. Diagnostics (Basel) 2021;11:1089. [PMID: 34203584 DOI: 10.3390/diagnostics11061089] [Reference Citation Analysis]
29 Maher TM, Corte TJ, Fischer A, Kreuter M, Lederer DJ, Molina-molina M, Axmann J, Kirchgaessler K, Samara K, Gilberg F, Cottin V. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet Respiratory Medicine 2020;8:147-57. [DOI: 10.1016/s2213-2600(19)30341-8] [Cited by in Crossref: 132] [Cited by in F6Publishing: 66] [Article Influence: 66.0] [Reference Citation Analysis]
30 Lancaster LH. Utility of the six-minute walk test in patients with idiopathic pulmonary fibrosis. Multidiscip Respir Med 2018;13:45. [PMID: 30559965 DOI: 10.1186/s40248-018-0158-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
31 Suzuki A, Ando M, Kimura T, Kataoka K, Yokoyama T, Shiroshita E, Kondoh Y. The impact of high-flow nasal cannula oxygen therapy on exercise capacity in fibrotic interstitial lung disease: a proof-of-concept randomized controlled crossover trial. BMC Pulm Med 2020;20:51. [PMID: 32093665 DOI: 10.1186/s12890-020-1093-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Barnes H, Troy L, Lee CT, Sperling A, Strek M, Glaspole I. Hypersensitivity pneumonitis: Current concepts in pathogenesis, diagnosis, and treatment. Allergy 2022;77:442-53. [PMID: 34293188 DOI: 10.1111/all.15017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]